BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 5569639)

  • 1. Excitation of the parasympathetic ganglia of the canine urinary bladder through a muscarinic mechanism.
    Taira N; Matsumura S; Hashimoto K
    J Pharmacol Exp Ther; 1971 Jan; 176(1):93-100. PubMed ID: 5569639
    [No Abstract]   [Full Text] [Related]  

  • 2. Contraction of the urinary bladder by muscarinic ganglionic stimulants: possible existence of muscarinic receptor sites on its parasympathetic ganglia.
    Saxena PR
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):16-28. PubMed ID: 4403681
    [No Abstract]   [Full Text] [Related]  

  • 3. Excitation of the parasympathetic ganglia of the canine urinary bladder by a muscarinic ganglionic stimulant, 4-(m-chlorophenyl-carbamoyloxy)-2-butynyltrimethyl-ammonium chloride (McN-A-343).
    Taira N; Matsumura S; Hashimoto K
    Tohoku J Exp Med; 1968 Oct; 96(2):209-10. PubMed ID: 5708524
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of muscarinic ganglionic stimulation and blockade upon ganglion responses to DMPP and nicotine.
    Graça AS; Hilton JG; Silva AJ
    Arch Int Pharmacodyn Ther; 1970 Aug; 186(2):379-87. PubMed ID: 4331696
    [No Abstract]   [Full Text] [Related]  

  • 5. The actions of 5-hydroxytryptamine on the urinary bladder and on vesical autonomic ganglia in the cat.
    Saum WR; De Groat WC
    J Pharmacol Exp Ther; 1973 Apr; 185(1):70-83. PubMed ID: 4693187
    [No Abstract]   [Full Text] [Related]  

  • 6. Nicotinic and muscarinic activity of benzyltrimethyl-ammonium and its alpha-, beta- and gamma-substituted pyridylmethyltrimethylammonium analogs.
    Hamilton JT; Rubinstein HM
    J Pharmacol Exp Ther; 1968 Mar; 160(1):112-23. PubMed ID: 5639098
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of ganglionic agonists and antagonists on the cardiac sympathetic ganglia of the dog.
    Flacke W; Fleisch JH
    J Pharmacol Exp Ther; 1970 Jul; 174(1):45-55. PubMed ID: 5424703
    [No Abstract]   [Full Text] [Related]  

  • 8. [A modification of the isolated hypogastric nerve-vas deferens preparation from the guinea pig for assay of ganglionic actions].
    Watanabe M
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(2):221-7. PubMed ID: 4389237
    [No Abstract]   [Full Text] [Related]  

  • 9. Muscarinic postsynaptic events in the cat superior cervical ganglion in situ.
    Haefely W
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(2):119-43. PubMed ID: 4273717
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement of ganglionic muscarinic activity by gallamine.
    Gardier RW; Ganansia MF; Delaunois AL; Hamelberg W
    Anesthesiology; 1974 May; 40(5):494-7. PubMed ID: 4150775
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of denervation on the sensitivity of the superior cervical ganglion of the cat to acetylcholine and McN-A-343.
    Vickerson FH; Varma DR
    Can J Physiol Pharmacol; 1969 Mar; 47(3):255-9. PubMed ID: 5767243
    [No Abstract]   [Full Text] [Related]  

  • 12. Ganglionic activity of 1-(2-bromophenyl)-3-(trimethyl-ammonium)-1-propene bromide (S-11-127).
    Kiekendol PL; Woodbury RA; Elko EE
    Arch Int Pharmacodyn Ther; 1972 Mar; 196(1):25-35. PubMed ID: 5059366
    [No Abstract]   [Full Text] [Related]  

  • 13. The action of arecoline on the superior cervical ganglion of the cat.
    Krstić MK
    Arch Int Pharmacodyn Ther; 1971 Dec; 194(2):238-52. PubMed ID: 5126062
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison between the ganglionic effects of decamethonium and those of eserine. Studies on the mechanism of disinversion of nicotinic acetylcholine after ganglioplegics].
    Hazard R; Boissier JR; Renier E; Renier-Cornec A
    C R Seances Soc Biol Fil; 1970 Sep; 164(2):251-4. PubMed ID: 4394625
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of arecoline on transmission through the superior cervical ganglion of the cat.
    Krstić MK
    Arch Int Pharmacodyn Ther; 1971 Dec; 194(2):253-8. PubMed ID: 4331176
    [No Abstract]   [Full Text] [Related]  

  • 16. The actions of several psychoactive agents upon the muscarinic mechanisms in the superior cervical ganglion of the cat.
    Chinn C; Weber LJ
    Neuropharmacology; 1974 Jan; 13(1):39-52. PubMed ID: 4150907
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the acute and chronic depressor actions of nicotine in the rat.
    Wenzel DG; Azmeh N; Clark IJ
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):23-36. PubMed ID: 5111323
    [No Abstract]   [Full Text] [Related]  

  • 18. Actions of anticholinesterase agents upon ganglionic transmission in the dog.
    Gillis RA; Flacke W; Garfield JM; Alper MH
    J Pharmacol Exp Ther; 1968 Oct; 163(2):277-86. PubMed ID: 4300677
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of the cholinergic and ganglionic-stimulant drugs on the isolated bovine iris sphincter.
    DeSantis LM; Patil PN
    Arch Int Pharmacodyn Ther; 1971 Apr; 190(2):249-60. PubMed ID: 5575579
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of ivory shell toxin on the parasympathetic ganglia of the dog urinary bladder.
    Taira N; Iwatsuki K; Hashimoto K; Hirayama H
    Tohoku J Exp Med; 1972 Jun; 107(2):191-2. PubMed ID: 4641113
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.